Sinotherapeutics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	143.88	407.11	225.79	641.79	763.15	511.66
Short-Term Investments	-	-	-	107.21	44.09	-
Trading Asset Securities	633.46	339.34	507.74	-	-	-
Cash & Short-Term Investments	777.34	746.45	733.53	749	807.23	511.66
Cash Growth	5.99%	1.76%	-2.07%	-7.21%	57.77%	17.85%
Accounts Receivable	72.43	86.25	110.97	78.47	71.27	44.09
Other Receivables	9.68	3.24	0.3	0.57	-	-
Receivables	82.11	89.49	111.27	79.04	71.27	44.09
Inventory	65.04	72.55	102.42	84.61	29.38	40.43
Other Current Assets	30.82	26.38	29.1	39.36	45.83	22.66
Total Current Assets	955.31	934.87	976.32	952.01	953.71	618.83
Property, Plant & Equipment	362.23	363.88	344.34	271.41	255.92	115.09
Long-Term Investments	84.6	84.27	64.42	64.2	49.1	69.99
Goodwill	16.22	16.22	18.39	18.39	18.39	-
Other Intangible Assets	13.32	14.98	21.65	27.59	32.47	41.16
Long-Term Deferred Tax Assets	18.46	19.01	19.33	14.29	16.45	16.08
Long-Term Deferred Charges	0.37	0.46	0.92	1.21	1.99	3.15
Other Long-Term Assets	3.55	4.41	7.94	12.54	4.3	1.5
Total Assets	1,454	1,438	1,453	1,362	1,332	865.81
Accounts Payable	26.22	25.86	16.75	13.34	8.42	8.01
Accrued Expenses	6.16	10.68	26.49	14.69	11.58	14.19
Current Portion of Long-Term Debt	0.01	0.02	-	-	-	-
Current Portion of Leases	-	-	0.01	0.06	0.32	0.78
Current Income Taxes Payable	2.82	2.97	6.97	1.28	0.45	7.85
Current Unearned Revenue	34.32	29.91	30.44	48.01	56.8	46.78
Other Current Liabilities	17.45	13.51	22.54	13.33	12.47	11.92
Total Current Liabilities	86.98	82.96	103.19	90.72	90.05	89.52
Long-Term Leases	-	-	-	0.02	1.2	3.66
Long-Term Unearned Revenue	53.89	58.43	74.72	58.09	61.12	64.62
Long-Term Deferred Tax Liabilities	2.21	2.25	2.39	2.53	2.68	2.82
Other Long-Term Liabilities	2.48	2.48	-	-	-	-
Total Liabilities	145.56	146.12	180.3	151.36	155.05	160.62
Common Stock	453.34	453.34	453.34	453.34	453.34	408
Additional Paid-In Capital	512.91	512.92	513.57	512.89	512.89	179.23
Retained Earnings	378.43	361.86	342.22	244.16	211.19	118.26
Treasury Stock	-36.13	-36.13	-36.13	-	-	-
Comprehensive Income & Other	-0.04	-0.02	-	-0.13	-0.15	-0.31
Shareholders' Equity	1,309	1,292	1,273	1,210	1,177	705.19
Total Liabilities & Equity	1,454	1,438	1,453	1,362	1,332	865.81
Total Debt	0.01	0.02	0.01	0.09	1.52	4.44
Net Cash (Debt)	777.33	746.43	733.53	748.92	805.71	507.22
Net Cash Growth	5.99%	1.76%	-2.05%	-7.05%	58.85%	16.82%
Net Cash Per Share	1.80	1.73	1.61	1.59	1.91	1.24
Filing Date Shares Outstanding	414.08	366.74	449	449.15	453.34	408
Total Common Shares Outstanding	414.08	366.74	449	453.34	453.34	408
Working Capital	868.33	851.91	873.13	861.29	863.66	529.31
Book Value Per Share	3.16	3.52	2.84	2.67	2.60	1.73
Tangible Book Value	1,279	1,261	1,233	1,164	1,126	664.02
Tangible Book Value Per Share	3.09	3.44	2.75	2.57	2.48	1.63
Buildings	-	-	216.23	211.68	54.29	52.41
Machinery	-	-	183.49	160.89	145.6	135.93
Construction In Progress	-	-	80.75	15.35	153.61	4.68

Source: S&P Global Market Intelligence. Standard template. Financial Sources.